ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia.
Metrics to compare | IPD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIPDPeersSector | |
---|---|---|---|---|
P/E Ratio | −4.5x | −3.5x | −0.5x | |
PEG Ratio | 0.00 | −0.17 | 0.00 | |
Price/Book | 3.0x | 4.2x | 2.6x | |
Price / LTM Sales | 8.3x | 3.4x | 3.3x | |
Upside (Analyst Target) | 218.8% | 42.0% | 42.8% | |
Fair Value Upside | Unlock | 7.5% | 6.5% | Unlock |